Drug Profile
Diaplasinin
Alternative Names: PAI-749Latest Information Update: 14 Aug 2009
Price :
$50
*
At a glance
- Originator Wyeth
- Class Antithrombotics; Indoles; Small molecules
- Mechanism of Action Plasminogen activator inhibitor-1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 06 Jun 2004 Phase-I clinical trials in Thrombosis in USA (PO)
- 31 Dec 2003 Preclinical trials in Thrombosis in USA (PO)